Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052545 · ClinicalTrials.gov registry record · NA
Asymptomatic Bacteriuria Guideline Implementation Study
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,598
- Enrollment target
NCT01052545: Completed NA study, sponsored by VA Office of Research and Development.
NCT01052545 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,598 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01052545, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,598 participants
- Enrollment target
Study Summary
Overtreatment of asymptomatic bacteriuria (ABU) is a quality, safety, and cost issue, particularly as unnecessary antibiotics lead to emergence of resistant pathogens. The investigators' proposal to bring clinical practice in line with published guidelines has significant potential to reduce unnecessary antibiotic use for ABU in the VA healthcare system, thus improving the quality and safety of veterans' healthcare. The investigators' study will also provide important insights about how to implement and sustain evidence-based clinical practice within VA hospitals.
Interventions
- BEHAVIORAL Audit-Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,598 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01052545
The ClinicalTrials.gov registry entry for NCT01052545 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,598 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Audit-Feedback is the first listed.
NCT01052545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01052545 about?
NCT01052545 is a clinical study titled "Asymptomatic Bacteriuria Guideline Implementation Study". Overtreatment of asymptomatic bacteriuria (ABU) is a quality, safety, and cost issue, particularly as unnecessary antibiotics lead to emergence of resistant pathogens. The investigators' proposal to bring clinical practice in line with published guidelines has significant potential to reduce unneces...
What is the current status of trial NCT01052545?
This trial is currently completed. It is a NA study. The enrollment target is 1,598 participants. The study started on 2011-07. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01052545?
The interventions under investigation include: Audit-Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT01052545?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.